Our Services
Medical Information
Helpful Resources
Published on: 7/2/2026
Before starting GLP-1 therapy, patients should complete several baseline evaluations to ensure safety and effectiveness. Key labs include fasting glucose, HbA1c, kidney and liver function tests, complete blood count, and a lipid panel. Specialized assessments—such as thyroid function, pancreatic enzymes (amylase and lipase), an ECG, and pregnancy testing when applicable—are also recommended. Equally important is a thorough review of your medical history, current medications, supplements, allergies, and lifestyle habits to identify potential risks and optimize dosing and tolerability.
Because GLP-1 readiness depends on how your symptoms and health history align with these factors, the smartest first step is to clarify what you're experiencing. Take a free, instant, online symptom check to better understand your symptoms and confidently navigate your next steps toward safe, effective treatment.
Reviewed for medical accuracy: 07/02/2026
GLP-1 receptor agonists (often called "GLP-1s") have become a powerful tool in managing type 2 diabetes, obesity, and certain metabolic disorders. Before starting injections, a thorough, comprehensive health screening helps ensure safety, optimize dosing, and identify potential risks. Here's what you and your doctor should review and test before beginning GLP-1 therapy.
GLP-1s work by mimicking the body's natural glucagon-like peptide-1 hormone, which regulates blood sugar, slows stomach emptying, and influences appetite. Because these medications affect multiple organ systems, pre-treatment tests can:
A solid baseline also makes it easier to spot changes once you're on therapy, ensuring any side effects or complications are addressed promptly.
Before starting GLP-1 injections, most clinicians will order the following basic panels:
Fasting Blood Glucose and HbA1c
Complete Metabolic Panel (CMP)
Complete Blood Count (CBC)
Lipid Profile
Depending on your personal and family history, additional tests may be needed:
Thyroid Function Tests (TSH, free T4)
Pancreatic Enzymes (Amylase, Lipase)
Electrocardiogram (ECG)
Pregnancy Test
Vitamin B12 Level
Lab tests are only part of the picture. A thorough review of your health history and a focused physical exam will cover:
Medical Conditions
Current Medications and Supplements
Allergies and Past Reactions
Lifestyle Factors
Family History
Before initiating therapy, a candid discussion helps set expectations and reduce anxiety:
Encourage questions so you feel fully informed. If you have any new or unexplained symptoms—such as severe abdominal pain, persistent heartburn, or chest discomfort—it's important to seek medical advice right away.
If you're ever unsure about new or changing symptoms before or after starting GLP-1 therapy, try using a Medically approved LLM Symptom Checker Chat Bot to get personalized guidance and determine whether you should monitor at home or contact your healthcare provider right away.
Certain findings on pre-treatment tests can prompt a delay or modification of your GLP-1 plan:
Your doctor will weigh the benefits and risks and discuss whether GLP-1 therapy, dose changes, or even a different class of medication is best for you.
Once injections begin, a follow-up schedule helps ensure safety and effectiveness:
Frequent check-ins allow for timely dose adjustments and early detection of side effects.
GLP-1 receptor agonists offer significant advantages:
However, no therapy is risk-free. Up-front screening and ongoing monitoring help you reap the most benefit with the least risk.
Always discuss your results and any concerns with your healthcare provider. If you experience serious or life-threatening symptoms, seek immediate medical attention. And remember to speak to a doctor before making any decisions about your health or treatment plan.
(References)
* American Diabetes Association. 10. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. *Diabetes Care*, vol. 47, suppl. 1, 2024, pp. S158-S177. doi:10.2337/dc24-S010.
* Garber, A. J., et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary. *Endocrine Practice*, vol. 26, no. 1, 2020, pp. 107-133. doi:10.4158/CS-2019-0527.
* Nauck, M. M., & Meier, J. J. GLP-1 receptor agonists: mechanisms of action, clinical applications, and safety profile. *Nature Reviews Endocrinology*, vol. 17, no. 6, 2021, pp. 349-366. doi:10.1038/s41574-021-00481-2.
* Lingvay, I., et al. Initiating and optimizing GLP-1 receptor agonist therapy in type 2 diabetes: A practical guide for clinicians. *Diabetes, Obesity and Metabolism*, vol. 24, no. 1, 2022, pp. 1-13. doi:10.1111/dom.14555.
* Smits, M. M., & van Raalte, D. H. Safety of GLP-1 receptor agonists: focus on pancreatitis, gallbladder, and thyroid. *Current Opinion in Endocrinology, Diabetes and Obesity*, vol. 28, no. 1, 2021, pp. 21-27. doi:10.1097/MED.0000000000000623.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.